Literature DB >> 23313358

Cognitive insight as an indicator of competence to consent to treatment in schizophrenia.

Stéphane Raffard1, Guillaume Fond, Marie Brittner, Catherine Bortolon, Alexandra Macgregor, Jean-Phillipe Boulenger, Marie-Christine Gely-Nargeot, Delphine Capdevielle.   

Abstract

The processes underlying the ability to make decisions about recommended treatments remain poorly understood in schizophrenia. The aim of this study was to explore the relationships between capacity to consent to medication and cognitive biases in 60 schizophrenia patients. Main measures included the MacArthur Competence Assessment tool for Treatment (MacCAT-T) and the Beck Cognitive Insight Scale (BCIS). After Bonferroni's correction for multiple correlations, the Self-Reflectiveness dimension of the BCIS was significantly associated with the dimension "Reasoning" of the MacCAT-T. Cognitive therapy, by enhancing patients' Self-Reflectiveness and considering alternative explanations, could lead to better capacity to consent to treatment in schizophrenia.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Year:  2013        PMID： 23313358     DOI： 10.1016/j.schres.2012.12.011

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


  7 in total

1.  The impact of cognitive insight, self-stigma, and medication compliance on the quality of life in patients with schizophrenia.

Authors:  Yin-Ju Lien; Hsin-An Chang; Yu-Chen Kao; Nian-Sheng Tzeng; Chien-Wen Lu; Ching-Hui Loh
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-07-29       Impact factor: 5.270

2.  The Effect of Reducing the "Jumping to Conclusions" Bias on Treatment Decision-Making Capacity in Psychosis: A Randomized Controlled Trial With Mediation Analysis.

Authors:  David T Turner; Angus MacBeth; Amanda Larkin; Steffen Moritz; Karen Livingstone; Alison Campbell; Paul Hutton
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

3.  The capacity of schizophrenia and bipolar disorder individuals to make autonomous decisions about pharmacological treatments for their illness in real life: A scoping review.

Authors:  Enric Vincens Pons; Luis Salvador-Carulla; Alfredo Calcedo-Barba; Silvia Paz; Thomas Messer; Bruno Paccardi; Scott L Zeller
Journal:  Health Sci Rep       Date:  2020-08-09

4.  Promoting insight and recovery in the context of the "insight paradox".

Authors:  Lawrence H Yang; Shana S Samuel; Charisse Tay; Young Cho
Journal:  Schizophr Res       Date:  2020-05-24       Impact factor: 4.662

5.  Insight as a social identity process in the evolution of psychosocial functioning in the early phase of psychosis.

Authors:  H S Klaas; A Clémence; R Marion-Veyron; J-P Antonietti; L Alameda; P Golay; P Conus
Journal:  Psychol Med       Date:  2016-11-21       Impact factor: 7.723

6.  Informed consent in psychiatry outpatients.

Authors:  Smita N Deshpande; Nagendra Narayan Mishra; Triptish Bhatia; Kiran Jakhar; Satnam Goyal; Srikant Sharma; Ankur Sachdeva; Mona Choudhary; Gyan Deep Shah; Roberto Lewis-Fernandez; Sushrut Jadhav
Journal:  Indian J Med Res       Date:  2020-01       Impact factor: 2.375

7.  Recent Neurobiological Insights into the Concept of Insight in Psychosis.

Authors:  Starlin Vijay Mythri; Y Sanjay
Journal:  Indian J Psychol Med       Date:  2016 May-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.